NCT00162253 Study of BMS-587101 in Patients With Moderate to Severe Psoriasis Status TERMINATED Phase PHASE2
NCT00162227 An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection Status NO_LONGER_AVAILABLE Phase N/A
NCT00162201 An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy Status COMPLETED Phase PHASE1
NCT00162188 An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada Status NO_LONGER_AVAILABLE Phase N/A
NCT00162123 A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies Status COMPLETED Phase PHASE2
NCT00162097 Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT00160329 Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia Status COMPLETED Phase PHASE3
NCT00158405 Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN) Status COMPLETED Phase PHASE3
NCT00153842 A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00152698 Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia Status WITHDRAWN Phase PHASE3
NCT00149591 The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial) Status UNKNOWN Phase NA
NCT00148109 Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas Status COMPLETED Phase PHASE2
NCT00144937 Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease Status UNKNOWN Phase PHASE4
NCT00142428 Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma Status COMPLETED Phase PHASE2